| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.099 | 0.09 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |